CytoDyn (CYDY) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free CYDY Stock Alerts $0.15 0.00 (-1.68%) (As of 05:33 PM ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest CytoDyn Short Interest DataCurrent Short Volume4,711,300 sharesPrevious Short Volume4,680,600 sharesChange Vs. Previous Month+0.66%Dollar Volume Sold Short$683,138.50Short Interest Ratio / Days to Cover1.5Last Record DateApril 15, 2024Outstanding Shares992,872,000 sharesPercentage of Shares Shorted0.47%Today's Trading Volume398,176 sharesAverage Trading Volume2,631,737 sharesToday's Volume Vs. Average15% Short Selling CytoDyn ? Sign up to receive the latest short interest report for CytoDyn and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCYDY Short Interest Over TimeCYDY Days to Cover Over TimeCYDY Percentage of Float Shorted Over Time Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. CytoDyn Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20244,711,300 shares $683,138.50 +0.7%N/A1.5 $0.15 3/31/20244,680,600 shares $764,107.95 -8.4%N/A1.6 $0.16 3/15/20245,107,100 shares $855,439.25 -1.0%N/A0.7 $0.17 2/29/20245,159,800 shares $1.33 million +9.2%N/A0.7 $0.26 2/15/20244,724,300 shares $798,595.67 -25.2%N/A0.8 $0.17 1/15/202410,691,100 shares $2.24 million -1.9%N/A3.1 $0.21 Get the Latest News and Ratings for CYDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter. 12/31/202310,893,600 shares $2.12 million +0.3%N/A1.8 $0.20 12/15/202310,863,000 shares $3.07 million -16.2%N/A1.2 $0.28 11/30/202312,960,200 shares $2.22 million 0.0%N/A2.6 $0.17 11/15/202312,965,900 shares $2.20 million -0.9%N/A6.7 $0.17 10/31/202313,087,700 shares $2.05 million +0.2%N/A5 $0.16 10/15/202313,058,200 shares $2.25 million -11.3%N/A7.5 $0.17 9/30/202314,723,600 shares $2.73 million -0.4%N/A8.3 $0.19 9/15/202314,785,400 shares $2.81 million +0.1%N/A9.2 $0.19 8/31/202314,770,500 shares $3.12 million -8.1%N/A8.6 $0.21 8/15/202316,067,600 shares $3.58 million -40.0%N/A2.2 $0.22 7/31/202326,765,000 shares $5.59 million +0.3%N/A7.8 $0.21 7/15/202326,695,600 shares $6.96 million -0.1%N/A10.5 $0.26 6/30/202326,722,500 shares $7.22 million -0.8%N/A11.1 $0.27 6/15/202326,948,200 shares $6.79 million -0.2%N/A9.9 $0.25 5/31/202327,009,000 shares $7.07 million -3.3%N/A14.2 $0.26 5/15/202327,921,000 shares $7.40 million +1.7%N/A13.9 $0.27 4/30/202327,460,800 shares $8.04 million -1.8%N/A18.5 $0.29 4/15/202327,965,300 shares $8.45 million +3.2%N/A6.7 $0.30 3/31/202327,096,500 shares $9.75 million +1.4%N/A11.2 $0.36 3/15/202326,726,800 shares $10.00 million +2.4%N/A5.6 $0.37 2/28/202326,113,800 shares $8.38 million +2.7%N/A7.2 $0.32 2/15/202325,428,900 shares $7.08 million -2.7%N/A6.8 $0.28 1/31/202326,140,000 shares $6.88 million -1.5%N/A6.9 $0.26 1/15/202326,528,000 shares $6.63 million -4.1%N/A6.7 $0.25 12/30/202227,656,900 shares $6.22 million -11.7%N/A2.7 $0.23 12/15/202231,304,500 shares $10.02 million -4.6%N/A10.7 $0.32 11/30/202232,811,200 shares $11.81 million -3.3%N/A13.5 $0.36 11/15/202233,929,800 shares $13.40 million -5.0%N/A16.1 $0.40 10/31/202235,699,900 shares $12.25 million -5.1%N/A17.8 $0.34 10/15/202237,621,300 shares $16.55 million -5.9%N/A16.9 $0.44 9/30/202239,993,600 shares $16.60 million +0.7%N/A11.8 $0.42 9/15/202239,705,000 shares $24.02 million -2.1%N/A23.3 $0.61 8/31/202240,549,900 shares $21.15 million -8.8%N/A11.2 $0.52 8/15/202244,456,900 shares $36.79 million -11.7%N/A4.8 $0.83Mysterious Gold Leverage Just Announced (Ad)World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. CYDY Short Interest - Frequently Asked Questions What is CytoDyn's current short interest? Short interest is the volume of CytoDyn shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 4,680,600 shares of CYDY short. Learn More on CytoDyn's current short interest. What is a good short interest ratio for CytoDyn? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CYDY shares currently have a short interest ratio of 2.0. Learn More on CytoDyn's short interest ratio. Is CytoDyn's short interest increasing or decreasing? CytoDyn saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 4,680,600 shares, a drop of 8.4% from the previous total of 5,107,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CytoDyn's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to CytoDyn: CervoMed Inc. (0.60%), Regulus Therapeutics Inc. (9.44%), Capricor Therapeutics Inc (11.11%), Cybin Inc. (6.62%), Newron Pharmaceuticals S.p.A. (0.25%), I-Mab (1.45%), Incannex Healthcare Inc. (0.78%), Biophytis S.A. (29.23%), Syros Pharmaceuticals, Inc. (9.89%), Sagimet Biosciences Inc. (19.41%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short CytoDyn stock? Short selling CYDY is an investing strategy that aims to generate trading profit from CytoDyn as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CytoDyn? A short squeeze for CytoDyn occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CYDY, which in turn drives the price of the stock up even further. How often is CytoDyn's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYDY, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: CRVO Short Interest RGLS Short Interest CAPR Short Interest CYBN Short Interest NWPHF Short Interest IMAB Short Interest IXHL Short Interest BPTS Short Interest SYRS Short Interest SGMT Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CYDY) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings